Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | interleukin-1 receptor-associated kinase 4 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | hypothetical protein, conserved | 0.0288 | 1 | 0.5 |
Onchocerca volvulus | Equilibrative nucleoside transporter, putative homolog | 0.0081 | 0.0634 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.0634 | 0.5 |
Onchocerca volvulus | Equilibrative nucleoside transporter, putative homolog | 0.0081 | 0.0634 | 0.5 |
Entamoeba histolytica | nucleoside transporter, putative | 0.0081 | 0.0634 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0288 | 1 | 0.5 |
Trypanosoma cruzi | hypothetical protein | 0.0288 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.0634 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.0634 | 0.5 |
Brugia malayi | hypothetical protein | 0.0081 | 0.0634 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0288 | 1 | 1 |
Echinococcus granulosus | equilibrative nucleoside transporter 3 | 0.0081 | 0.0634 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0081 | 0.0634 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0288 | 1 | 0.5 |
Echinococcus multilocularis | equilibrative nucleoside transporter 3 | 0.0081 | 0.0634 | 1 |
Echinococcus granulosus | equilibrative nucleoside transporter | 0.0081 | 0.0634 | 0.5 |
Trypanosoma cruzi | hypothetical protein | 0.0288 | 1 | 0.5 |
Brugia malayi | Nucleoside transporter family protein | 0.0081 | 0.0634 | 0.5 |
Trypanosoma brucei | nucleoside 2-deoxyribosyltransferase | 0.0288 | 1 | 0.5 |
Echinococcus multilocularis | equilibrative nucleoside transporter protein | 0.0081 | 0.0634 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.